Getting a Wegovy Refill: What to Consider Before You Re-order

Is a refill a repeat, or a fresh decision every time?

This is a question our prescribers hear most weeks, and the honest answer sits somewhere in the middle. A Wegovy refill isn't a straightforward repeat in the way a blood pressure medicine might be, because both your dose and your clinical picture can change between pens. The prescriber reviewing your refill is asking: is this dose still right, are there any new side effects that need addressing, and has your weight responded in line with what the treatment was expected to do?

The NHS medicines information for semaglutide is clear that treatment continues under clinical oversight, not independently. That means each re-order sits alongside a review, even if it's brief. At nume (sorry, at a GPhC-registered pharmacy like ours) every repeat order is personally re-reviewed by a prescriber before anything is dispensed. Nothing is automated. A real clinician reads your update, not a queuing system.

If you're mid-titration (working up through the dose schedule toward the 2.4mg maintenance level) each refill is also a decision about whether you're ready for the next step, or whether staying at the current dose for another four weeks is the right call. That's a clinical judgement, not a calendar one.

What happens if there's been a gap in your treatment?

Breaks happen. Stock issues, travel, illness, cost, or simply losing track of timing, whatever the reason, a gap in Wegovy treatment is something to flag to your prescriber rather than quietly paper over. This matters because Wegovy's effect on appetite and gastric emptying can diminish during a break, and restarting at the dose you left off can bring back the gastrointestinal side effects that most people experience early in treatment.

The general clinical approach for a significant gap is to restart at a lower dose to let the body readjust, but what counts as significant, and how far back to step, depends on the individual. Your prescriber will want to know how long the break was before advising. If you're exploring what Wegovy might realistically do for you, it's worth knowing that a consistent dosing schedule is part of what shapes the result. Gaps don't reset everything, but they can affect how you tolerate restarting.

Side effects on restart can sometimes feel more pronounced than people expect. Nausea, constipation and fatigue are the most common ones people encounter. If you're experiencing symptoms that feel unusual or severe, your prescriber and the Patient Information Leaflet that comes with your pen are the right places to turn, not a search engine.

Private refill vs NHS supply: the practical reality

Most people refilling Wegovy in the UK are doing so privately, because NHS access sits within specialist weight management services with significant waiting lists in most areas. The NICE recommendation for semaglutide (TA875) ties NHS prescribing to those services and to a two-year maximum duration, conditions that don't apply to private treatment under the same terms.

Privately, the refill process sits with the pharmacy or clinic you're registered with. The cost context matters here too: since Eli Lilly raised its UK list price in September 2025, the private market for semaglutide pens has reflected broader changes in what injectable weight-loss treatment costs, you can read more about how Wegovy is priced in the UK and what that includes. A refill from a regulated provider should always come with clinical review, a valid prescription, and a clear supply chain. If a provider is offering refills without those elements, that's a warning sign worth taking seriously.

Legitimate pharmacies can be checked on the GPhC register. Worth a two-minute check if you're unsure about any provider you're considering.

Making the decision: stay the course or reassess?

Sometimes a refill appointment surfaces a bigger question, whether to continue at all. People stop Wegovy for different reasons: cost, side effects, good progress they want to consolidate, or simply wanting a break. Equally, some people who've been on treatment for a while start to wonder whether the dose they're on is still doing enough, or whether a move toward the newer semaglutide options, including the semaglutide prefilled syringe format, is worth discussing with their prescriber.

The SK3 framing applies here: the refill isn't just a logistics task. It's a moment to take stock. Has weight loss continued? Have side effects settled? Is the current dose sustainable? If you're weighing up whether to continue, what the trial evidence says about long-term results might help frame the conversation with your prescriber. So might looking at the full picture of what Wegovy involves as a treatment, or exploring other weight-loss approaches alongside it.

If you're ready to continue and want your refill reviewed by a GPhC-registered prescriber (the same day, with free next-working-day delivery once approved) check your eligibility with our clinical team.